English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

A prospective and double-blind study was conducted on 40 patients with coronary bypass operation. In 20 patients 8 ng of PGI2 per min and kg body-weight were infused during ECC. The amount of heparin administered per kg was the same in both groups. Drop in platelet count during ECC however was less and bleeding times were longer under PGI2 infusion. βTG was released from platelets immediately after onset of ECC and remained at a nearly constant level. PF 4 concentration in plasma increased continuously over the whole period of ECC (1600 ng/ml or 1200 ng/ml, max. values). PGI2 infusion leads to a significant reduction of the amount of both platelet constituents released (950 ng/ml or 750 ng/ml, max. values). After ECC βTG and PF 4 dropped down immediately to preoperative values. No differences in per-/ postoperative blood loss and in the amount of heparin bound to patients' antithrombin III could be observed.

Effect Of Prostacyclin (PGI2) On The Release Of β Thrombo- Globulin (βTG) And Platelet Factor 4 (PF 4) During Extracorporeal Circulation (ECC)